Zydus Wellness Ltd

Indian pharma companies operating in the US are clawing back pricing power with a differentiated pipeline. Here we identify the valuation assigned to US portfolio in light of that pipeline.

Zydus’ Sugar Free commands 95 per cent market share in India

Company sees consumer sentiment gradually improving in rural areas

The fall in stock price to ₹1,622.15 offers a good entry point for long-term investors

Eyes direct distribution to about one million outlets in the next few years

Buzzing stocks: ITC, Lupin, Motilal Oswal, TVS Motor, LIC Housing, GIC HF, Route Mobile, IOB, Zydus Life, Ashoka Buildcon, Ramco Industries, Manappuram Fin, Interglobe Aviation

Drug offers new line of treatment besides the current statin therapy

Stocks to Watch: Bharti Airtel, Tata Power, Zydus Lifesciences, Lara Supergenerics, Vakrangee, PNB Housing Fin, Gufic Biosciences,kKalapana Ind, Brightcom group, IIFL Wealth

Sharp correction in the past nine months offer a window of opportunity; the stock currently trades at Rs 346 levels

 Shares in red after results announcement 

Revenue jumped to Rs 52 crore as against Rs 23 crore in the same quarter last year